Obesity, Hormones & GLP-1s: Dr. Spencer Nadolsky on Ozempic, Wegovy, Mounjaro, and Women’s Health

Échec de l'ajout au panier.

Veuillez réessayer plus tard

Échec de l'ajout à la liste d'envies.

Veuillez réessayer plus tard

Échec de la suppression de la liste d’envies.

Veuillez réessayer plus tard

Échec du suivi du balado

Ne plus suivre le balado a échoué

Obesity, Hormones & GLP-1s: Dr. Spencer Nadolsky on Ozempic, Wegovy, Mounjaro, and Women’s Health

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

In this episode of The Body Pod, we sit down with Dr. Spencer Nadolsky — The GLP-1 Doc to uncover the truth about GLP-1 medications like Ozempic, Wegovy, and Mounjaro, and what they really mean for women’s health, hormones, and sustainable weight loss.

We dig into the real science behind appetite, metabolism, and obesity, and why weight gain isn’t a failure of willpower but a matter of biology and hormones — especially for women in perimenopause and menopause. Dr. Nadolsky explains the myths around diet culture, Big Pharma, and compounded GLP-1 medications, plus how the medical system often overlooks women struggling with weight, fatigue, and hormonal changes.

Whether you’re curious about GLP-1 drugs, navigating menopause weight gain, or frustrated by conflicting weight loss advice, this conversation will leave you informed, empowered, and hopeful about your health journey.

Pas encore de commentaire